Skip to main content Help with accessibility Skip to main navigation

RHEUMATOID ARTHRITIS: high cost drugs pathway

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 28 - Apr - 2022
Body System:
Red
RHEUMATOID ARTHRITIS: high cost drugs pathway

Failure of intensive therapy with a combination of standard DMARDs (usually methotrexate, hydroxychloroquine and sulphasalazine)